Skip to main content
TipRanks
Go Ultimate75% OFF

Kyntra Bio (KYNB) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

KYNB Analyst Ratings

Strong Buy
4Ratings
3Buy1Hold0Sell
Based on 4 analysts giving stock ratings to Kyntra Bio in the past 3 months

KYNB Stock 12 Month Forecast

CHF32.74▲(0.00% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Kyntra Bio in the last 3 months. The average price target is CHF 32.74 with a high forecast of CHF 35.49 and a low forecast of CHF 28.89. The average price target represents a ― change from the last price of ―.
Highest Price TargetCHF35.49Average Price TargetCHF32.74Lowest Price TargetCHF28.89

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:KYNB
Price TargetArticle
Maxim GroupCHF28.89buy―Initiated10/13/26
H.C. WainwrightCHF35.49buy―Reiterated10/05/26
Lake StreetCHF33.84buy―Initiated09/17/26
William Blair―hold―Reiterated08/31/26
OppenheimerCHF28.89buy―Reiterated08/14/26
Rodman & RenshawCHF24.76buy―Initiated06/09/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kyntra Bio

3 Months
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate4/13 ratings generated profit
31%
Average Return
-17.32%

Copying Matthew Keller's trades and holding each position for 3 Months would result in 30.77% of your transactions generating a profit, with an average return of -17.32% per trade.

1 Year
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/13 ratings generated profit
0%
Average Return
-35.65%

Copying Matthew Keller's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -35.65% per trade.

2 Years
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/13 ratings generated profit
0%
Average Return
-54.48%

Copying Matthew Keller's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -54.48% per trade.

KYNB Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for KYNB
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy34564
Buy00000
Hold12220
Sell00000
Strong Sell00000
total46784

In the current month, KYNB has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KYNB average Analyst price target in the past 3 months is 32.74.

KYNB Financial Forecast

CHF-5CHF-3CHF-1CHF1CHF3Q1 2026Q3 2026Q4 2026
ConsensusCHF0.03

KYNB Earnings Forecast

Next quarter’s earnings estimate for KYNB is CHF 0.03 with a range of ― to ―. The previous quarter’s EPS was CHF 0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF-1.2MCHF-143,493.3CHF949,900.5CHF2MCHF3.1MQ1 2026Q3 2026Q4 2026
ConsensusCHF1.48M

KYNB Sales Forecast

Next quarter’s sales forecast for KYNB is CHF 1.48M with a range of ― to ―. The previous quarter’s sales results were CHF 1.48M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

KYNB Stock Forecast FAQ

What is CH:KYNB’s average 12-month price target, according to analysts?
Based on analyst ratings, Kyntra Bio’s 12-month average price target is CHF32.74.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Kyntra Bio a Buy, Sell or Hold?
Kyntra Bio has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Kyntra Bio’s share price target?
The average share price target for Kyntra Bio is CHF32.74. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF35.49, and the lowest forecast is CHF28.89. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Kyntra Bio?
Kyntra Bio’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Kyntra Bio?
To buy shares of CH:KYNB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.